This grant funds mature cancer research with preliminary data that promises near-term clinical impact, especially within the Military Health System, and supports single or partnered investigators.
Funder: Dept. of the Army -- USAMRAA
Due Dates: June 26, 2026: Pre-Application (Preproposal) | October 5, 2026: Full Application | October 8, 2026: End of Application Verification Period
Funding Amounts: Up to $1.5M (single PI) or $2.0M (Partnering PI option) total costs for up to 3 years; ~30 awards anticipated from $45M total program funding.
Summary: Supports mature research with near-term impact on clinical cancer care in congressionally directed topic areas relevant to military health.
Key Information: Applications must address a PRCRP topic area and include preliminary data; clinical trials are allowed; both pre- and full applications required.
This opportunity supports high-impact, translational cancer research that will have a near-term effect on clinical care, specifically addressing one of the congressionally directed FY26 Peer Reviewed Cancer Research Program (PRCRP) Topic Areas and strategic goals. Projects must demonstrate direct relevance to military health, including the needs of Service Members, Veterans, and their families, and are expected to accelerate promising findings toward clinical applicability or improved patient outcomes. Both single Principal Investigator (PI) and Partnering PI options are available, and clinical trials are permitted.